Zombie Viruses of the Permafrost
By KIM BELLARD
We’ve had some cold weather here lately, as has much of the nation. Not necessarily record-breaking, but uncomfortable for millions of people. It’s the kind of weather that causes climate change skeptics to sneer “where’s the global warming now?” This despite 2023 being the warmest year on record — “by far” — and the fact that the ten warmest years since 1850 have all been in the last decade, according to NOAA.
One of the parts of the globe warming the fastest is the Arctic, which is warming four times as fast as the rest of the planet. That sounds like good news if you run a ...
Source: The Health Care Blog - January 24, 2024 Category: Consumer Health News Authors: matthew holt Tags: Health Policy Climate Change Kim Bellard Viruses Source Type: blogs
Better Health Care Tests, Faster
This article looks at some specific problems and solutions.
Speeding up Test Development
We’ve seen with COVID-19 how quickly a virus can evolve and how hard it is to design both tests and vaccinations that accommodate different variants. Virax Biolabs uses data from the World Health Organization and others to develop tests quickly. For instance, new viral variants tend to spread in the southern hemisphere before hitting the northern hemisphere in our Winter, so Virax can check existing data to prepare better tests for the North.
The company is developing a T-cell diagnostics and profiling platform called Virax Immu...
Source: EMR and HIPAA - June 13, 2023 Category: Information Technology Authors: Andy Oram Tags: Health IT Company Healthcare IT Hospital - Health System Interoperability CLIA COVID-19 Hydreight Immunexpress ixlayer Laboratories Labs Rolland Carlson Sepsis Sepsis Lab Tests Septicyte Shane Madden testing Tomasz George Source Type: blogs
Surviving monkeypox: a story of compassionate care and an emerging disease outbreak
Mr. Sanchez had been feeling unwell for days before he decided to visit the emergency room. When I walked into his room, I immediately noticed that he was scared and anxious. His sore throat had been persistent for five days and was now so severe that he couldn’t eat or drink anything. He had also
Read more…
Surviving monkeypox: a story of compassionate care and an emerging disease outbreak originally appeared in KevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - May 1, 2023 Category: General Medicine Authors: Ton La, Jr., MD, JD Tags: Conditions Infectious Disease Source Type: blogs
Rapid Test for Mpox Virus Developed
Researchers at Penn State have engineered a rapid testing technology for mpox, previously known as monkeypox. The mpox virus, which is transmitted through close contact with an infected person and that spread around the world last year, left healthcare staff grappling with a new problem. As the disease can be transmitted before symptoms arise, diagnosis is important in helping to stop the spread. However, conventional diagnostic approaches, such as PCR, are time consuming and require access to expensive lab equipment and qualified technicians. This latest technology uses gold nanoparticles that can bind viral nucleic acid....
Source: Medgadget - April 25, 2023 Category: Medical Devices Authors: Conn Hastings Tags: Diagnostics Medicine Public Health monkey pox mpox penn PennState Source Type: blogs
TWiV 984: Clinical update with Dr. Daniel Griffin
In his weekly clinical update Dr. Griffin discusses the political polarization of COVID-19 treatments among physicians and laypeople in the United States, seven alternatives to evidence-based medicine, Malawi’s cholera death toll crosses 1,300 in its deadliest outbreak on record, impact of coronavirus infections on pediatric patients at a tertiary pediatric hospital, maternal mRNA COVID-19 vaccination during … TWiV 984: Clinical update with Dr. Daniel Griffin Read More » (Source: virology blog)
Source: virology blog - February 18, 2023 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation influenza Long Covid monkeypox monoclonal antibody Omicron pandemic poliovirus SARS-CoV-2 vaccine vaccine booster variant of concern viruses Source Type: blogs
TWiV 984: Clinical update with Dr. Daniel Griffin
In his weekly clinical update Dr. Griffin discusses the political polarization of COVID-19 treatments among physicians and laypeople in the United States, seven alternatives to evidence-based medicine, Malawi’s cholera death toll crosses 1,300 in its deadliest outbreak on record, impact of coronavirus infections on pediatric patients at a tertiary pediatric hospital, maternal mRNA COVID-19 vaccination during […] (Source: virology blog)
Source: virology blog - February 18, 2023 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation influenza Long Covid monkeypox monoclonal antibody Omicron pandemic poliovirus SARS-CoV-2 vaccine vaccine booster variant of concern viruses Source Type: blogs
A physician in denial after being diagnosed with COVID-19
Over the last three years, we have faced the original COVID-19, followed by Omicron, Delta, and monkeypox. It is apropos that on the third anniversary of COVID-19, we are facing the tripledemic of COVID, influenza, and RSV. After almost three years of not getting COVID-19, I started believing that my childhood fantasies about me being
Read more…
A physician in denial after being diagnosed with COVID-19 originally appeared in KevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - December 11, 2022 Category: General Medicine Authors: Alen Voskanian, MD Tags: Conditions COVID Infectious Disease Source Type: blogs
UK strategy for mpox control: 2022 to 2023
UK Health Security Agency -This strategy outlines the UK ’s four nation plan to continue reducing monkeypox (mpox) transmission over the next twelve months. It builds on the system-wide response so far this year and sets out the current position and the long-term goal to eliminate mpox transmission in the UK. The strategic goal over the next six to twel ve months is focused on: reducing harm; suppressing current UK transmission; minimising UK transmission from imported cases; and contributing to a reduction in the global burden.StrategyUK Health Security Agency - publications (Source: Health Management Specialist Library)
Source: Health Management Specialist Library - December 8, 2022 Category: UK Health Authors: The King ' s Fund Library Tags: Public health and health inequalities Source Type: blogs
Bonus Features – November 13, 2022 – HCA extends 30-year relationship with MEDITECH, cost of care replaces pandemic as top reason to defer care, and more
This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s so much happening out there in healthcare IT we aren’t able to cover in our full articles, we still want to make sure you’re informed of all the latest news, announcements, and stories happening to help you better do your job.
News and Research
HCA Healthcare signed a new agreement for a large-scale deployment of MEDITECH Expanse, continuing a relationship with the EHR vendor that has spanned three decades and been recognized with the 2021 CHIME Colla...
Source: EMR and HIPAA - November 13, 2022 Category: Information Technology Authors: Brian Eastwood Tags: EMR-EHR Healthcare IT AbsoluteCare Atropos Health BARDA Bioverge Cerner CharmHealth directtrust HCA Healthcare HCTec Healthcare IT Today Bonus Features Hugh Chatham Memorial Hospital Julie McCorkle Lifehouse MDaudit Meditec Source Type: blogs
TWiV 953: Clinical update with Dr. Daniel Griffin
In his weekly clinical update Dr. Griffin discusses high demand for Amoxicillin causing shortages amid child RSV surge, epidemiologic and clinical features of children and adolescents aged <18 years with monkeypox, low risk of SARS-Cov-2 transmission by fomites, nucleocapsid antigenemia is a marker of acute SARS-CoV-2 infection, impact of community masking on COVID-19, protection against Omicron from vaccination and … TWiV 953: Clinical update with Dr. Daniel Griffin Read More » (Source: virology blog)
Source: virology blog - November 12, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation Long Covid marburg virus monkeypox monoclonal antibody Omicron pandemic poliovirus SARS-CoV-2 vaccine vaccine booster variant of concern viruses Source Type: blogs
TWiV 953: Clinical update with Dr. Daniel Griffin
In his weekly clinical update Dr. Griffin discusses high demand for Amoxicillin causing shortages amid child RSV surge, epidemiologic and clinical features of children and adolescents aged <18 years with monkeypox, low risk of SARS-Cov-2 transmission by fomites, nucleocapsid antigenemia is a marker of acute SARS-CoV-2 infection, impact of community masking on COVID-19, protection against Omicron from vaccination and […] (Source: virology blog)
Source: virology blog - November 12, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation Long Covid marburg virus monkeypox monoclonal antibody Omicron pandemic poliovirus SARS-CoV-2 vaccine vaccine booster variant of concern viruses Source Type: blogs
TWiV 951: Clinical update with Dr. Daniel Griffin
In his weekly clinical update Dr. Griffin discusses Influenza incidence and vaccine effectiveness during the southern hemisphere influenza season in Chile, Nirsevimab for prevention of RSV infection in healthy late-preterm and term infants, severe Monkeypox in hospitalized patients, reinfections with different SARS-CoV-2 Omicron subvariants, impact of community masking on COVID-19 in Bangladesh, unadjuvanted intranasal spike vaccine elicits protective […] (Source: virology blog)
Source: virology blog - November 5, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation influenza Long Covid marburg virus monkeypox monoclonal antibody Omicron pandemic poliovirus SARS-CoV-2 vaccine vaccine booster variant of concern Source Type: blogs
TWiV 951: Clinical update with Dr. Daniel Griffin
In his weekly clinical update Dr. Griffin discusses Influenza incidence and vaccine effectiveness during the southern hemisphere influenza season in Chile, Nirsevimab for prevention of RSV infection in healthy late-preterm and term infants, severe Monkeypox in hospitalized patients, reinfections with different SARS-CoV-2 Omicron subvariants, impact of community masking on COVID-19 in Bangladesh, unadjuvanted intranasal spike vaccine elicits protective … TWiV 951: Clinical update with Dr. Daniel Griffin Read More » (Source: virology blog)
Source: virology blog - November 5, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation influenza Long Covid marburg virus monkeypox monoclonal antibody Omicron pandemic poliovirus SARS-CoV-2 vaccine vaccine booster variant of concern Source Type: blogs
TWiV 949: Clinical update with Dr. Daniel Griffin
In his weekly clinical update Dr. Griffin discusses progress toward poliomyelitis eradication in Pakistan, polio by the numbers , influenza and COVID-19 vaccination coverage among health care personnel, phase 1/2a safety and immunogenicity of an adenovirus 26 vector RSV vaccine encoding prefusion F in adults 18–50 years and RSV seropositive children 12–24 months, receipt of first and second doses of JYNNEOS vaccine for prevention of Monkeypox, distinguishing SARS-CoV-2 persistence and reinfection, Novavax NVX-COV2373 triggers potent neutralization of Omicron sub-lineages, association between regular physical activity a...
Source: virology blog - October 29, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation influenza Long Covid marburg virus monkeypox monoclonal antibody Omicron pandemic poliovirus SARS-CoV-2 vaccine vaccine booster variant of concern Source Type: blogs
